von Finck M
Universitätsklinik, für Anästhesie und Transfusionsmedizin, Tübingen, Germany.
Transfus Clin Biol. 1994;1(3):221-5. doi: 10.1016/s1246-7820(05)80032-1.
Autologous preoperative plasmapheresis which is being performed at the University Hospital of Tübingen since 1984 in advance of surgical, orthopaedic or gynecologic operations, constitutes, in combination with intraoperative autotransfusion (IAT), an optimal method to compensate high losses of intravascular volume. Unlike all other procedures which also substitute lost volume (such as infusion of electrolytic solutions or plasma expanders, haemodilution, retransfusion of preoperatively donated autologous blood, transfusion of homologous plasma or foreign blood) this method grants optimal clotting as well as intravascular retention of volume and in addition to this excludes every risk of infection. Although the therapeutic advantages of autologous preoperative plasmapheresis are well known and confirmed by our statistics (about 75% of the patients do not need any foreign blood), the method is rarely practiced in Germany and mainly performed in specialized hospitals (e.g. in the orthopaedic departments of Tübingen, Ulm, Hamburg, Hannover or Essen). This unfortunate situation is obviously due to some of the following, primarily logistic problems. First of all the procedure of autologous preoperative plasmapheresis needs relatively long planning in advance of the operation (between 2 and 4 weeks) and a number of surgeons renounces the method--even if the patient's medical condition is appropriate and no higher costs are to be expected. The above mentioned alternatives of compensating blood losses are preferred, even if they are in no way comparable in their efficiency. Secondly, in Germany autologous preoperative plasmapheresis is mostly performed by an anaesthetist, who is, however, under our laws obliged to reinfuse the plasma himself, which he has taken from a patient.(ABSTRACT TRUNCATED AT 250 WORDS)
自1984年以来,图宾根大学医院在外科、骨科或妇科手术前进行自体术前血浆置换,该方法与术中自体输血(IAT)相结合,是补偿血管内容量大量丢失的最佳方法。与所有其他替代丢失容量的方法(如输注电解质溶液或血浆扩容剂、血液稀释、术前捐献的自体血回输、输注同源血浆或异体血)不同,这种方法能实现最佳凝血以及血管内容量的保留,此外还排除了所有感染风险。尽管自体术前血浆置换的治疗优势众所周知且经我们的统计得到证实(约75%的患者不需要任何异体血),但该方法在德国很少实施,主要在专科医院(如图宾根、乌尔姆、汉堡、汉诺威或埃森的骨科部门)进行。这种不幸的情况显然是由于以下一些主要是后勤方面的问题。首先,自体术前血浆置换程序在手术前需要相对较长的提前规划时间(2至4周),而且一些外科医生放弃了这种方法——即使患者的病情合适且预计不会有更高成本。即使上述替代失血补偿方法的效率远不可比,人们还是更倾向于选择它们。其次,在德国,自体术前血浆置换大多由麻醉师进行,然而,根据我们的法律,麻醉师有义务亲自将从患者身上采集的血浆回输。(摘要截取自250词)